SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $75,000 | +33.9% | 772 | +28.0% | 0.00% | – |
Q4 2014 | $56,000 | +7.7% | 603 | -19.6% | 0.00% | – |
Q3 2014 | $52,000 | -28.8% | 750 | +7.4% | 0.00% | -100.0% |
Q2 2014 | $73,000 | +25.9% | 698 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $58,000 | +31.8% | 698 | +2.9% | 0.00% | – |
Q4 2013 | $44,000 | -63.0% | 678 | -64.0% | 0.00% | -100.0% |
Q3 2013 | $119,000 | +176.7% | 1,884 | +84.7% | 0.00% | – |
Q2 2013 | $43,000 | – | 1,020 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 10,660,432 | $989,182,000 | 10.10% |
BB BIOTECH AG | 1,130,476 | $104,897,000 | 3.40% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 80,000 | $7,423,000 | 3.31% |
Opus Point Partners Management, LLC | 20,002 | $1,856,000 | 1.84% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,847,094 | $356,972,000 | 1.77% |
SECTORAL ASSET MANAGEMENT INC | 363,884 | $33,765,000 | 1.52% |
Cormorant Asset Management, LP | 100,000 | $9,279,000 | 1.43% |
Tekla Capital Management LLC | 223,020 | $20,694,000 | 0.97% |
Lamond Capital Partners LLC | 15,390 | $1,428,000 | 0.94% |
Squarepoint Ops LLC | 6,700 | $622,000 | 0.60% |